Safety and efficacy of Metrodora Therapeutics’ Low Iron MTbLF (Low Iron MTbLF) formulations with or without Essential Elements Zinc and Manganese during coadministration with oral antibiotic and for an additional 11 weeks following antibiotic treatment on recurrence of symptomatic bacterial vaginosis (BV)

Authors
Category Primary study
Registry of TrialsAustralian New Zealand Clinical Trials Registry
Year 2025
This article has no abstract
Epistemonikos ID: eb7f65d875ff00815c2001fdff70efde2086244c
First added on: Apr 26, 2025